Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.10+0.22 (+3.74%)
Close on Nov 13, 2026Market cap $114.13MP/E –Yield –
Trinity Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Trinity Biotech's enterprise value was $103.18M on Nov 11, 2026, against $561.76M a year earlier. Over the last 5 years it ranged from $103.18M to $785.38M, with a median of $380.96M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $103.18M | -75.7% |
| 2025 | Dec 31, 2025 | $424.89M | +115.6% |
| 2024 | Dec 31, 2024 | $197.05M | -21.1% |
| 2023 | Dec 29, 2023 | $249.59M | -5.6% |
| 2022 | Dec 30, 2022 | $264.44M | -42.5% |
| 2021 | Dec 31, 2021 | $460.24M | -84.5% |
| 2020 | Dec 31, 2020 | $2.98B | +248.9% |
| 2019 | Dec 31, 2019 | $853.43M | -52.5% |
| 2018 | Dec 31, 2018 | $1.80B | -58.6% |
| 2017 | Dec 29, 2017 | $4.35B | -23.5% |
| 2016 | Dec 30, 2016 | $5.68B | – |
See a number that looks wrong?